120 related articles for article (PubMed ID: 1689608)
1. Serum basic fetoprotein in patients with renal cell carcinoma.
Gohji K; Ishii M; Nagata H; Matsumoto O; Kamidono S
Cancer; 1990 Mar; 65(6):1405-11. PubMed ID: 1689608
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of serum basic fetoprotein--comparative study of serum immunosuppressive acid protein].
Gohji K; Arakawa S; Matsumoto O; Kamidono S; Oshima H; Nagata H; Iwamoto T; Hirooka K; Shimatani N; Inoue T
Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):711-8. PubMed ID: 2474083
[TBL] [Abstract][Full Text] [Related]
3. Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma.
Pummer K; Pürstner P; Auner HL; Stettner H; Trummer H; Penkoff H; Rauchenwald M
Br J Urol; 1994 Jun; 73(6):612-4. PubMed ID: 8032825
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers.
Masuda H; Kurita Y; Suzuki K; Fujita K; Aso Y
Br J Urol; 1997 Jul; 80(1):25-9. PubMed ID: 9240175
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
6. Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma.
Igarashi T; Tobe T; Kuramochi H; Akakura K; Ichikawa T; Hamano S; Suzuki N; Furuya Y; Ito H
Jpn J Clin Oncol; 2001 Jan; 31(1):13-7. PubMed ID: 11256835
[TBL] [Abstract][Full Text] [Related]
7. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
[TBL] [Abstract][Full Text] [Related]
8. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
[TBL] [Abstract][Full Text] [Related]
9. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.
Ueda T; Yasumasu T; Uozumi J; Naito S
Br J Urol; 1993 Oct; 72(4):409-12. PubMed ID: 8261296
[TBL] [Abstract][Full Text] [Related]
11. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
12. Serum immunosuppressive acidic protein in renal cell carcinoma.
Ueda T
Urol Res; 1986; 14(2):101-3. PubMed ID: 3727211
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
14. Tissue polypeptide-specific antigen in renal cell carcinoma.
Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
[TBL] [Abstract][Full Text] [Related]
15. Serum ferritin: a tumor marker for renal cell carcinoma.
Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
[TBL] [Abstract][Full Text] [Related]
16. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers in metastatic renal cell carcinoma.
Dexeus FH; Logothetis CJ; Sella A; Fitz K; Striegel A; Amato RJ; Liu FJ
Urology; 1991 Jul; 38(1):6-10. PubMed ID: 1714107
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
Kawata N; Yamaguchi K; Hirakata H; Hachiya T; Yoshida T; Takimoto Y
Urology; 2005 Oct; 66(4):736-40. PubMed ID: 16230127
[TBL] [Abstract][Full Text] [Related]
19. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Aoyagi Y; Mori S; Naitoh A; Yanagi M; Suzuki Y; Suda T; Isokawa O; Igarashi H; Takahashi T; Isemura M; Asakura H
Nephron; 1996; 74(2):409-14. PubMed ID: 8893165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]